期刊文献+

细胞周期调节正负控蛋白 被引量:2

Cell-cycle regulates positive and negative regulatory proteins
暂未订购
导出
摘要 According to their action on the cell-cycle,cell-cycle, regulatory proteins can be dividedinto two groups: positive and negative cell-cycle regulatory poroeins.Positive group includes cyclin,cyclin-de-pendent kinase(CDK), and downstream targets such as retinoblastoma protein (pRb) and so on. The proteins in-volved in the negative group are named cyclin-kinase inhibitors(CKI) as a whole, consisting of CIP/KIP familyand INK4 family.Cyclins associate with CDKs to form a variety of active complexes, which in trm leads to thephosphorylation of pRb ane other downstream proteins,and this realizes the positive regulatory action.CKI playsa negative regulatory role by inhibiting the activity of cyllin- CDK. By interplaying each other, the two regulatorygroups control the intiation phase transitions,exit and termination of the cell-cycle. According to their action on the cell-cycle,cell-cycle, regulatory proteins can be dividedinto two groups: positive and negative cell-cycle regulatory poroeins.Positive group includes cyclin,cyclin-de-pendent kinase(CDK), and downstream targets such as retinoblastoma protein (pRb) and so on. The proteins in-volved in the negative group are named cyclin-kinase inhibitors(CKI) as a whole, consisting of CIP/KIP familyand INK4 family.Cyclins associate with CDKs to form a variety of active complexes, which in trm leads to thephosphorylation of pRb ane other downstream proteins,and this realizes the positive regulatory action.CKI playsa negative regulatory role by inhibiting the activity of cyllin- CDK. By interplaying each other, the two regulatorygroups control the intiation phase transitions,exit and termination of the cell-cycle.
作者 齐晖 戴勇
机构地区 深圳市人民医院
出处 《中国病理生理杂志》 CAS CSCD 北大核心 1999年第10期956-958,共3页 Chinese Journal of Pathophysiology
  • 相关文献

参考文献4

  • 1Chen I T,Oncogene,1996年,12卷,595页
  • 2Lee E,Curr Opin Cell Biol,1995年,7卷,773页
  • 3Feng X H,J Biol Chem,1995年,270卷,24237页
  • 4Li R,Nature,1994年,6卷,443页

同被引文献18

  • 1Donnellan R, Chetty R. Cyclin D1 and human neoplasia [J] .J clin Pathol: Mol , Part, 1998, 51:1~7.
  • 2Zhang S Y, Caamano J, Cooper F, et al .Immunohistochemistry of cyclinD in human breast cancer [J]. Am J Clin Pathol 1994. 102:695~698.
  • 3丁翠敏 徐金升 孙志学 等.应用流式细胞术检测肺癌组织中p16蛋白表达[J].中华病理学杂志,1999,28(1):57-57.
  • 4LABAER J, GAERRTT M D, STEVENSON L F, et al. New functional activities for P21 family of CDK inhibitors [ J ]. GenesDev, 1997, 11: 847.
  • 5CULUMREN I, ROBERTS J M. Cell cycle - cancer [ J]. J Na- tional Cancer Institute, 1995, 87: 1499.
  • 6YU Q, GENG Y, SICINSKI P. Specific protection against breast cancers by cyclinD1 ablation[J]. Nature, 2001, 411:1017 - 1021.
  • 7LIN S, YU H S. Clinical significance of nucleostemin expression and its correlation with cyclin D1 expression in malignant ovarian tumors [J]. Int J Gynecol Cancer, 2011, 21 (7): 1166 - 1171.
  • 8CHOSCHZICK M, HESS S, TENNSTEDT P, et al. Role of cyc- lin D1 amplification and expression in vulvar carcinomas [ J ]. Hum Pathol, 2012, 43(9) : 1386-1393.
  • 9BLAGOSKLONNY M V, PARDEE A B. Exploiting cancer cell cycling for selective protection of normal cells [J]. Cancer Res, 2001, 61:4301 -4305.
  • 10武玉东,吴海,马腾骧,吴长利.膀胱移行细胞癌中p16基因的改变[J].中华病理学杂志,1999,28(1):39-41. 被引量:6

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部